AZN
AstraZeneca PLC trades as AZN and has a market capitalization of $286.27 B, making it the #50 largest US-listed company by market value. This page tracks AstraZeneca PLC through 1,004 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-05-29
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
| Filing | Type | Filed |
|---|---|---|
| 6-K | - | 2026-05-18 |
| 6-K | - | 2026-05-18 |
| 6-K | - | 2026-05-18 |
| 6-K | - | 2026-05-14 |
| Insider trade | 4 | 2026-05-08 |
| 6-K | - | 2026-05-01 |
| 6-K | - | 2026-05-01 |
| 6-K | - | 2026-05-01 |
Featured websiteAstraZeneca Clinical Trials Featured websiteOpen Innovation
Featured websiteAstraZeneca Clinical Trials Featured websiteOpen Innovation
Featured websiteAstraZeneca Clinical Trials Featured websiteOpen Innovation
We announced the results of 16 positive Phase 3 studies during the year and now have 16 blockbuster medicines. The momentum across our company ...
The largest companies sharing AstraZeneca PLC's SEC industry classification (pharmaceutical preparations).
AstraZeneca PLC (AZN) has a market capitalization of $286.27 B as of 2026-05-29, ranking #50 among US-listed companies.